Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coronavirus Update: WHO Aims For 2 Billion Doses, Oral Vaccine Selected For Warp Speed

Shares In Vaxart Rocket On News

Executive Summary

As vaccine development progresses, worldwide deaths caused by SARS-CoV-2 continue to rise, and now exceed 500,000, with more than 10 million confirmed cases. Daily new infections also hit a new peak, as some US states are being forced to consider lockdowns again as the situation worsens.

You may also be interested in...



CanSino Coronavirus Vaccine Approved For Military Use In China

The move may signal China is accelerating the vaccine to hit the general market soon, but a false impression of the vaccine’s safety may be potentially misleading, says one regulatory expert.

Global ‘Fair Access’ Coronavirus Vaccine Fund Launched, AZ Doubles Output Target

Pharma is looking to GAVI to oversee a fair distribution and avoid ‘vaccine nationalism’ – but countries can still sign bilateral deals with companies.

Pipeline Watch: Seven Approvals And 10 Phase III Updates

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Topics

Related Companies

UsernamePublicRestriction

Register

SC142486

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel